Iscan, M. Et Al. 2014. CYP2E1, GSTO1 and TP53 polymorphisms, response to chemotherapy and survival in advanced non-small cell lung cancer patients. 50th Congress of the European-Societies-of-Toxicology , (Edinburgh, Saint Helena).

Iscan, M., Volkan, K., ADA, A. O., Bilgen, S., Kunak, S. C., & Gulhan, M., (2014). CYP2E1, GSTO1 and TP53 polymorphisms, response to chemotherapy and survival in advanced non-small cell lung cancer patients . 50th Congress of the European-Societies-of-Toxicology, Edinburgh, Saint Helena

Iscan, Mumtaz Et Al. "CYP2E1, GSTO1 and TP53 polymorphisms, response to chemotherapy and survival in advanced non-small cell lung cancer patients," 50th Congress of the European-Societies-of-Toxicology, Edinburgh, Saint Helena, 2014

Iscan, Mumtaz Et Al. "CYP2E1, GSTO1 and TP53 polymorphisms, response to chemotherapy and survival in advanced non-small cell lung cancer patients." 50th Congress of the European-Societies-of-Toxicology , Edinburgh, Saint Helena, 2014

Iscan, M. Et Al. (2014) . "CYP2E1, GSTO1 and TP53 polymorphisms, response to chemotherapy and survival in advanced non-small cell lung cancer patients." 50th Congress of the European-Societies-of-Toxicology , Edinburgh, Saint Helena.

@conferencepaper{conferencepaper, author={Mumtaz Iscan Et Al. }, title={CYP2E1, GSTO1 and TP53 polymorphisms, response to chemotherapy and survival in advanced non-small cell lung cancer patients}, congress name={50th Congress of the European-Societies-of-Toxicology}, city={Edinburgh}, country={Saint Helena}, year={2014}}